Aytu Bioscience Stock Buy Hold or Sell Recommendation
| AYTU Stock | USD 1.62 0.02 1.25% |
Given the investment horizon of 90 days and your conservative risk appetite, our recommendation regarding Aytu BioScience is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aytu BioScience given historical horizon and risk tolerance towards Aytu BioScience. When Macroaxis issues a 'buy' or 'sell' recommendation for Aytu BioScience, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Aytu BioScience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide. Note, we conduct extensive research on individual companies such as Aytu and provide practical buy, sell, or hold advice based on investors' constraints. Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Aytu |
Execute Aytu BioScience Buy or Sell Advice
The Aytu recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aytu BioScience. Macroaxis does not own or have any residual interests in Aytu BioScience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aytu BioScience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Aytu BioScience Trading Alerts and Improvement Suggestions
| Aytu BioScience generated a negative expected return over the last 90 days | |
| Aytu BioScience may become a speculative penny stock | |
| Aytu BioScience has high historical volatility and very poor performance | |
| Aytu BioScience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 81 M. Net Loss for the year was (15.84 M) with profit before overhead, payroll, taxes, and interest of 66.63 M. | |
| Aytu BioScience currently holds about 23.81 M in cash with (1.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38. | |
| Aytu BioScience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500 |
Aytu BioScience Returns Distribution Density
The distribution of Aytu BioScience's historical returns is an attempt to chart the uncertainty of Aytu BioScience's future price movements. The chart of the probability distribution of Aytu BioScience daily returns describes the distribution of returns around its average expected value. We use Aytu BioScience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aytu BioScience returns is essential to provide solid investment advice for Aytu BioScience.
| Mean Return | -0.5 | Value At Risk | -6.87 | Potential Upside | 3.40 | Standard Deviation | 4.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aytu BioScience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aytu Stock Institutional Investors
The Aytu BioScience's institutional investors refer to entities that pool money to purchase Aytu BioScience's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 880 | Jpmorgan Chase & Co | 2024-06-30 | 540 | Ubs Group Ag | 2024-06-30 | 308 | Advisor Group Holdings, Inc. | 2024-06-30 | 300 | Wells Fargo & Co | 2024-06-30 | 124 | Bank Of America Corp | 2024-06-30 | 92.0 | Atlantic Trust Group, Llc | 2024-06-30 | 83.0 | Group One Trading, Lp | 2024-06-30 | 37.0 | Goss Wealth Management Llc | 2024-06-30 | 21.0 | Nantahala Capital Management, Llc | 2024-09-30 | 1.1 M | Stonepine Capital Management Llc | 2024-06-30 | 472.5 K |
Aytu BioScience Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 37.0M | 1.6M | (30.5M) | 3.6M | (3.0M) | (2.8M) | |
| Free Cash Flow | (28.4M) | (28.3M) | (28.8M) | (5.1M) | (1.4M) | (1.5M) | |
| Depreciation | 6.2M | 9.2M | 10.3M | 8.8M | 8.3M | 8.7M | |
| Other Non Cash Items | (10.0M) | (4.5M) | 76.7M | (404K) | 7.9M | 4.6M | |
| Net Income | (13.6M) | (58.3M) | (110.2M) | (17.1M) | (15.8M) | (16.6M) | |
| End Period Cash Flow | 48.3M | 49.9M | 19.4M | 23.0M | 20.0M | 12.1M | |
| Net Borrowings | (16.2M) | (3.7M) | (5.2M) | (2.3M) | (2.1M) | (2.0M) | |
| Change To Netincome | 1.7M | 21.4M | 82.0M | 8.9M | 10.2M | 14.6M | |
| Change To Inventory | (7.0M) | 2.8M | 1.3M | (3.6M) | 2.3M | 2.4M | |
| Investments | (5.7M) | (2.8M) | (3.2M) | (117K) | (329K) | (345.5K) |
Aytu BioScience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aytu BioScience or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aytu BioScience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aytu stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.57 | |
β | Beta against Dow Jones | 0.47 | |
σ | Overall volatility | 4.43 | |
Ir | Information ratio | -0.14 |
Aytu BioScience Volatility Alert
Aytu BioScience exhibits very low volatility with skewness of -0.08 and kurtosis of 6.95. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aytu BioScience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aytu BioScience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aytu BioScience Fundamentals Vs Peers
Comparing Aytu BioScience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aytu BioScience's direct or indirect competition across all of the common fundamentals between Aytu BioScience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aytu BioScience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aytu BioScience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aytu BioScience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aytu BioScience to competition |
| Fundamentals | Aytu BioScience | Peer Average |
| Return On Equity | -0.47 | -0.31 |
| Return On Asset | -0.0106 | -0.14 |
| Profit Margin | (0.20) % | (1.27) % |
| Operating Margin | (0.04) % | (5.51) % |
| Current Valuation | 6.29 M | 16.62 B |
| Shares Outstanding | 6.15 M | 571.82 M |
| Shares Owned By Insiders | 2.43 % | 10.09 % |
| Shares Owned By Institutions | 34.04 % | 39.21 % |
| Number Of Shares Shorted | 192.76 K | 4.71 M |
| Price To Earning | (0.77) X | 28.72 X |
| Price To Book | 0.33 X | 9.51 X |
| Price To Sales | 0.12 X | 11.42 X |
| Revenue | 81 M | 9.43 B |
| Gross Profit | 66.63 M | 27.38 B |
| EBITDA | (1.01 M) | 3.9 B |
| Net Income | (15.84 M) | 570.98 M |
| Cash And Equivalents | 23.81 M | 2.7 B |
| Cash Per Share | 0.38 X | 5.01 X |
| Total Debt | 15.13 M | 5.32 B |
| Debt To Equity | 0.47 % | 48.70 % |
| Current Ratio | 1.02 X | 2.16 X |
| Book Value Per Share | 4.64 X | 1.93 K |
| Cash Flow From Operations | (1.39 M) | 971.22 M |
| Short Ratio | 10.45 X | 4.00 X |
| Earnings Per Share | (1.70) X | 3.12 X |
| Target Price | 8.0 | |
| Number Of Employees | 102 | 18.84 K |
| Beta | -1.4 | -0.15 |
| Market Capitalization | 9.84 M | 19.03 B |
| Total Asset | 118.09 M | 29.47 B |
| Retained Earnings | (319.97 M) | 9.33 B |
| Working Capital | (337 K) | 1.48 B |
| Current Asset | 6.36 M | 9.34 B |
Note: Insider Trading [view details]
Aytu BioScience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aytu . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aytu BioScience Buy or Sell Advice
When is the right time to buy or sell Aytu BioScience? Buying financial instruments such as Aytu Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aytu BioScience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hotels Thematic Idea Now
Hotels
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.